📄 Official sourceAdvisory
Stanford Medicine
Stanford Medicine researchers have created a new platform for studying human brain development by transplanting lab-grown cortical organoids into bioengineered mice. These mice, designed without a cerebral cortex, allowed the human brain tissue to grow and integrate with the mice's nervous system, including the spinal cord. The study, published in Nature on September 16, revealed previously unknown nerve-cell types and provides a powerful tool for investigating disorders like schizophrenia and autism.
This breakthrough builds on earlier work by Dr. Sergiu Pasca, who recently secured $14 million in funding to study neurodevelopmental disorders. The new model could accelerate the discovery of biological mechanisms underlying these conditions, potentially opening pathways to innovative treatments.
Investment implication: This advancement strengthens Stanford's position as a leader in neuroscience research, likely attracting increased funding and high-caliber academic talent. For you, this underscores the importance of monitoring Stanford's growing influence in securing partnerships and driving innovation in this field.